Ralf Reilmann

Ralf Reilmann publication distribution in Neuroscience in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Neuroscience in 2026. The highlighted bar marks where Ralf Reilmann sits on this spectrum.

Ralf Reilmann D-index placement in Neuroscience in 2026

The chart shows the D-index (discipline H-index) distribution of Neuroscience scientists ranked by Research.com in 2026. The highlighted bar marks where Ralf Reilmann sits on this spectrum.

Best Publications

• Huntington disease: natural history, biomarkers and prospects for therapeutics

  Christopher A Ross;Elizabeth Hoppes Aylward;Edward J Wild;Douglas R Langbehn

  1113
  Citations

• Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data.

  Sarah J Tabrizi;Douglas R Langbehn;Blair R Leavitt;Raymund A C Roos

  1076
  Citations

• Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data

  Sarah J Tabrizi;Rachael I Scahill;Gail N Owen;Alexandra Durr

  956
  Citations

• Technology in Parkinson's disease: Challenges and opportunities.

  Alberto J. Espay;Paolo Bonato;Fatta B. Nahab;Walter Maetzler

  688
  Citations

• Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: the 12-month longitudinal analysis

  Sarah J Tabrizi;Rachael I Scahill;Alexandra Durr;Raymund A C Roos

  686
  Citations

• Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data

  Sarah J Tabrizi;Ralph Reilmann;Raymond A C Roos;Alexandra Durr

  602
  Citations

• Identification of genetic variants associated with Huntington's disease progression: a genome-wide association study

  Davina J Hensman Moss;Antonio F Pardiñas;Douglas Langbehn;Kitty Lo

  347
  Citations

• A roadmap for implementation of patient‐centered digital outcome measures in Parkinson's disease obtained using mobile health technologies

  Alberto J. Espay;Jeffrey M. Hausdorff;Jeffrey M. Hausdorff;Jeffrey M. Hausdorff;Álvaro Sánchez‐Ferro;Jochen Klucken

  290
  Citations

• Diagnostic Criteria for Huntington's Disease Based on Natural History

  Ralf Reilmann;CM Blair R. Leavitt Md;Christopher A. Ross

  246
  Citations

• International Guidelines for the treatment of Huntington’s Disease

  Anne Catherine Bachoud-Lévi;Joaquim Ferreira;Renaud Massart;Katia Youssov

  189
  Citations

• Pridopidine for the treatment of motor function in patients with Huntington's disease (MermaiHD): a phase 3, randomised, double-blind, placebo-controlled trial

  Justo Garcia de Yebenes;Bernhard Landwehrmeyer;Ferdinando Squitieri;Ralf Reilmann

  189
  Citations

• MSH3 modifies somatic instability and disease severity in Huntington's and myotonic dystrophy type 1.

  Michael Flower;Vilija Lomeikaite;Marc Ciosi;Sarah Cumming

  169
  Citations

• Tapping linked to function and structure in premanifest and symptomatic Huntington disease

  N. Bechtel;R.I. Scahill;H.D. Rosas;T. Acharya

  169
  Citations

• Early changes in white matter pathways of the sensorimotor cortex in premanifest Huntington's disease

  Eve M. Dumas;Simon J.A. van den Bogaard;Margot E. Ruber;Ralf Reilmann

  163
  Citations

• Creatine supplementation lowers brain glutamate levels in Huntington's disease.

  Andreas Bender;Dorothee P. Auer;Thomas Merl;Ralf Reilmann

  155
  Citations

• Compensation in Preclinical Huntington's Disease: Evidence From the Track-On HD Study

  Stefan Klöppel;Sarah Gregory;Elisa Scheller;Lora Minkova

  152
  Citations

• Clinical impairment in premanifest and early Huntington's disease is associated with regionally specific atrophy

  Rachael I. Scahill;Nicola Z. Hobbs;Miranda J. Say;Natalie Bechtel

  139
  Citations

• Magnetic resonance spectroscopy biomarkers in premanifest and early Huntington disease

  A. Sturrock;C. Laule;J. Decolongon;R. Dar Santos

  132
  Citations

• Coordination of prehensile forces during precision grip in Huntington's disease

  Andrew M. Gordon;Lori Quinn;Ralf Reilmann;Karen Marder

  123
  Citations

• Safety and efficacy of pridopidine in patients with Huntington's disease (PRIDE-HD): a phase 2, randomised, placebo-controlled, multicentre, dose-ranging study.

  Ralf Reilmann;Ralf Reilmann;Andrew McGarry;Igor D Grachev;Juha-Matti Savola

  109
  Citations